Dociu N, Cojocel C, Baumann K
Small Animal Practice, Hamburg, F.R.G.
Toxicology. 1989 Feb;54(2):163-75. doi: 10.1016/0300-483x(89)90042-5.
Male and female Wistar rats were used to study the sex differences in nephrotoxic, ulcerogenic and lethal effects of phenylbutazone (PBZ). In one series of experiments, male and female rats were given daily oral doses of 25, 125, 250, 400 and 500 mg PBZ/kg for 7 days to assess mortality, gross and microscopic lesions of the stomach, intestine and kidneys and to determine the PBZ effects on renal protein and glucose excretion. In another series of experiments, PBZ effects on renal gluconeogenesis and p-aminohippurate (PAH) accumulation in renal cortical slices were measured 12 h after administration of the same PBZ doses to male and female rats. Reduced glutathione (GSH) depletion and malondialdehyde (MDA) content in kidney cortex and liver were determined 2 h after a single administration of 250 mg PBZ/kg to male and female rats. To measure the effects of PBZ on blood urea nitrogen (BUN), male and female rats were given a single dose of PBZ (125 mg/kg) and were sacrificed at different time intervals, from 0 to 48 h. Gross and microscopic examination of the kidneys and gastrointestinal tract showed more pronounced renal and gastrointestinal lesions in surviving female than in male rats at the same doses. In PBZ treated male rats, BUN did not differ from control rats 48 h after PBZ administration. In female rats, BUN increased from 18 to 96 mg/100 ml 48 h after PBZ administration. After 7 days of PBZ treatment there was a greater increase of protein excretion in female than in male rats, but there were almost no sex differences in glucose excretion. Twelve hours after PBZ administration, renal PAH accumulation and gluconeogenesis were not different from controls in male rats but decreased in a dose-dependent fashion in females. A significant depletion of GSH and a significant increase in MDA content in liver and renal cortex occurred in female but not in male rats. In conclusion, the PBZ treatment was associated with nephrotoxic and gastrointestinal effects which could be detected earlier and were greater in female than in male rats.
采用雄性和雌性Wistar大鼠研究保泰松(PBZ)的肾毒性、致溃疡作用和致死效应的性别差异。在一系列实验中,雄性和雌性大鼠连续7天每日经口给予25、125、250、400和500 mg PBZ/kg,以评估死亡率、胃、肠和肾脏的大体和微观病变,并确定PBZ对肾蛋白和葡萄糖排泄的影响。在另一系列实验中,给雄性和雌性大鼠给予相同剂量的PBZ 12小时后,测量PBZ对肾皮质切片中肾糖异生和对氨基马尿酸(PAH)蓄积的影响。给雄性和雌性大鼠单次给予250 mg PBZ/kg 2小时后,测定肾皮质和肝脏中还原型谷胱甘肽(GSH)耗竭和丙二醛(MDA)含量。为了测量PBZ对血尿素氮(BUN)的影响,给雄性和雌性大鼠单次给予PBZ(125 mg/kg),并在0至48小时的不同时间间隔处处死。肾脏和胃肠道的大体和微观检查显示,在相同剂量下,存活的雌性大鼠比雄性大鼠的肾脏和胃肠道病变更明显。在PBZ处理的雄性大鼠中,PBZ给药48小时后BUN与对照大鼠无差异。在雌性大鼠中,PBZ给药48小时后BUN从18 mg/100 ml增加到96 mg/100 ml。PBZ治疗7天后,雌性大鼠的蛋白排泄增加幅度大于雄性大鼠,但葡萄糖排泄几乎没有性别差异。PBZ给药12小时后,雄性大鼠的肾PAH蓄积和糖异生与对照无差异,但在雌性大鼠中呈剂量依赖性降低。雌性大鼠肝脏和肾皮质中GSH显著耗竭,MDA含量显著增加,而雄性大鼠则未出现这种情况。总之,PBZ治疗与肾毒性和胃肠道效应相关,雌性大鼠比雄性大鼠更早出现且效应更明显。